Euphorbia fischeriana (Fischer's Spurge)

CONSULTATION WITH A SPECIALIST

Product code:
$7.7
We recommend installing the IMO messenger for quick contact.
It is not blocked for now — DOWNLOAD IMO
Place an order via messengers:
Overview

Euphorbia fischeriana (Fischer's Spurge)

Product Name: Молочай Фишера, Euphorbia fischeriana, Fischers Wolfsmilch, euforbia de Fischer, euphorbe de Fischer, الفربيون فيشر, ยูโฟร์เบีย ฟิชเชอเรียน่า, Fischer evforbiyasi, Фишердин сүттүү чөбү, Fischer südlüotu, шири Фишер, Fišerio euforbijos, Fišera eiforbija, молочай Фішера, Fişer südlüotu, חלב-כלב פישר

Synonyms: Молочай корневищный, Fisher's spurge, Rhizome euphorbia, Rhizom-Wolfsmilch, euphorbia de rizoma, euphorbe à rhizome, الفربيون الجذمور, ยูโฟร์เบีย เหง้า, молочай лекарственный восточный, радикс молочая, молочай дальневосточный

Parts Used: rhizome, root, milky sap, aerial shoots, seeds, leaves, stems, flowers, latex.

Main Indications for Use of Euphorbia fischeriana: Hepatocellular carcinoma, pancreatic cancer, colorectal cancer, viral hepatitis B, chronic constipation, leukopenia, ascariasis, breast cancer, pulmonary tuberculosis, chronic bronchitis, chronic cholecystitis, prostatitis, neurodermatitis.

Use of Euphorbia fischeriana in Mixtures and Complexes: Prostate adenoma, chronic gastritis, hemorrhoids, endometrial hyperplasia, ovarian cyst, eczema, systemic lupus erythematosus, hypertension, infectious arthritis, liver cirrhosis.

Pharmacological Properties of Euphorbia fischeriana: antitumor, cytotoxic, immunomodulatory, antiviral, hepatoprotective, laxative, anthelmintic, antibacterial, anti-inflammatory, antiseptic, dermatoprotective, cardioprotective, antioxidant, analgesic, vasodilatory, antitussive.


Toxicity and Biosafety of Euphorbia fischeriana

The rhizome of Euphorbia fischeriana contains active diterpenoids, including ingenol esters, possessing high biological activity and potential toxicity. In preclinical studies, it has been established that extracts of this plant can cause dose-dependent damage to the gastrointestinal tract, kidneys, and liver when the therapeutic range is exceeded. In vivo studies on rodents have shown pronounced toxicity with parenteral administration.

Acute toxicity of the standard root extract of Euphorbia fischeriana was evaluated in mice. The threshold lethal dose (LD₅₀) with oral administration was 1.12 g/kg in males and 0.98 g/kg in females, which indicates moderate toxicity when used internally. However, with prolonged use or when using an unpurified extract form, signs of nephrotoxicity and hepatotoxicity were observed.

The studies also indicate that latex and milky sap can cause irritation of the skin and mucous membranes and eye burns on direct contact. Regular intake in high doses is contraindicated in hepatic or renal insufficiency, as well as in pediatric practice.

Reference: https://doi.org/10.1016/j.jep....


Pharmacodynamics — Euphorbia fischeriana

The pharmacodynamic properties of Euphorbia fischeriana are determined primarily by the presence of unique macrocyclic and polyoxygenated diterpenoids of the ingenol type, including fischerin and its derivatives. These compounds are key modulators of biological activity at the systemic and cellular levels. Their main action is realized through influence on cytokine regulation, redox homeostasis, and proliferative signaling cascades.

At the systemic level, extracts of Euphorbia fischeriana exhibit predominantly cytomodulatory, anti-inflammatory, and immunomodulatory action. There are confirmed data on a decrease in the production of pro-inflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and prostaglandin E2, due to inhibition of the activity of cyclooxygenase-2 (COX-2) and NO synthase (iNOS). Thus, the plant has a pronounced influence on local inflammatory reactions of the skin, mucous membranes, respiratory and digestive systems.

In addition, the fischeriane type of diterpenoids exhibits an influence on the apoptotic activity of cells, which is realized through modulation of the MAPK/ERK, PI3K/Akt signaling pathways and the caspase cascade. These effects are most pronounced with respect to actively proliferating cells, which has been confirmed in vitro on epithelial and lymphoid cell lines. Target systems include the immune, hematopoietic, and skin systems.

There are data on a modulating influence on the peripheral nervous system and gastrointestinal tract, due to the regulation of ion channels and sensory receptors, including TRPV1 and P2X. Such effects confirm the traditional use of the plant as a remedy affecting visceral sensitivity and smooth muscle tone.

Pharmacological studies also indicate the antioxidant properties of Euphorbia fischeriana extracts, associated with activation of endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) and suppression of lipid peroxidation. This action is important for protecting cell membranes during inflammatory and oxidative damage, especially in the tissues of the liver, intestines, and blood vessels.

At the level of endocrine regulation, an indirect effect has been revealed through suppression of aromatase and 5-alpha-reductase activity in animal models. These mechanisms, along with antiangiogenic action, expand the spectrum of pharmacological activity of Euphorbia fischeriana, especially in tissues sensitive to hormonal regulation.

Thus, the pharmacodynamics of Euphorbia fischeriana is realized through a combination of cytotoxic, antiproliferative, anti-inflammatory, and immunomodulatory effects with the involvement of enzyme, receptor, and signaling cellular mechanisms, including COX-2, iNOS, caspases, MAPK/ERK, TRPV1, and P2X receptors.

References:
https://doi.org/10.1016/j.jep....
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404039/
https://www.sciencedirect.com/science/article/abs/pii/S0367326X19301041
https://www.tandfonline.com/do...
https://pubs.rsc.org/en/conten...


Pharmacokinetics — Euphorbia fischeriana

The pharmacokinetic features of Euphorbia fischeriana largely depend on the route of administration, the chemical nature of the diterpenoids, and their degree of polarity. The most studied are oral forms of extracts and rhizome powders used in traditional medicine and preclinical models.

With oral administration, the main part of the active compounds is absorbed in the proximal parts of the small intestine, while the absorption efficiency is determined by the degree of lipophilicity of individual fractions. Polyoxygenated ingenol diterpenoids are characterized by moderate permeability and require the participation of specific transport proteins (P-gp, OATP) for transmembrane transport. Hydrophilic components, including glycosides and low-molecular-weight phenolic compounds, can be partially metabolized by the intestinal microflora to more accessible forms, enhancing their bioavailability.

The distribution of active substances occurs predominantly in highly vascularized tissues — the liver, kidneys, intestines, and lymphoid organs. A tendency of some compounds to accumulate in the reticuloendothelial system, as well as in the lipid fractions of cell membranes, has been discovered. Some studies have shown that metabolites can penetrate the blood-brain barrier; however, their concentrations remain subtherapeutic.

Metabolism occurs predominantly in the liver, with the participation of cytochrome P450 enzymes (especially the CYP3A4 and CYP2C9 isoforms), which leads to the formation of less toxic, water-soluble metabolites. Phase II enzymes — glucuronyltransferases and sulfotransferases — also participate. There are data on the possible inactivation of some compounds in the intestinal wall before systemic circulation.

Excretion is carried out predominantly through the kidneys (in the form of metabolites and partially in unchanged form) and with bile. It has been established that compounds with high molecular weight are prone to enterohepatic circulation. A small amount of semi-volatile components can be excreted through the lungs and skin, especially with prolonged intake.

Thus, the pharmacokinetics of Euphorbia fischeriana reflects the typical profile of herbal medicines containing diterpenoids and phenolic compounds: limited absorption, active metabolism in the liver, predominant excretion through the kidneys, and the participation of intestinal microflora in biotransformation.

References:
https://doi.org/10.1016/j.fito...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281992/
https://link.springer.com/article/10.1007/s11418-021-01558-8
https://www.sciencedirect.com/science/article/pii/S0378874112007067


Mechanisms of Action and Scientific Rationale — Euphorbia fischeriana

The pharmacological activity of Euphorbia fischeriana is due to the presence of macrocyclic and polyoxygenated diterpenoids, mainly derivatives of ingenol and fischeriane. These compounds demonstrate direct interaction with several signaling pathways, including NF-κB, MAPK/ERK, and PI3K/Akt, which has been confirmed by in vitro and in vivo studies. Suppression of the translocation of the nuclear factor NF-κB reduces the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), as well as inducible NO synthase (iNOS) and COX-2, which explains the anti-inflammatory and immunomodulatory effects.

References: https://www.sciencedirect.com/...; https://www.tandfonline.com/do...;https://www.ncbi.nlm.nih.gov/p...

The active components of the Euphorbia fischeriana rhizome also affect the mitochondrial pathways of apoptosis, activating caspase-3 and suppressing anti-apoptotic proteins of the Bcl-2 family. These mechanisms involve the regulation of the cell cycle and the expression of p53, which indicates a pronounced cytostatic and proliferatively selective action. Similar effects have been described with respect to epithelial and hematopoietic cells, while an influence on intracellular calcium metabolism and oxidative stress has been proven.

References: https://pubs.rsc.org/en/conten...; https://www.sciencedirect.com/...

The diterpenoids of Euphorbia fischeriana exhibit antioxidant activity due to the activation of the antioxidant response through the Nrf2/ARE pathway. This leads to an increase in the level of catalase, superoxide dismutase, and glutathione peroxidase. Simultaneously, the production of reactive oxygen species (ROS) is inhibited, which reduces oxidative tissue damage, especially in the liver, kidneys, and vascular endothelium. The ability of the plant's compounds to inhibit lipid peroxidation has also been confirmed.

References: https://link.springer.com/arti...;https://www.ncbi.nlm.nih.gov/p...

Some components of Euphorbia fischeriana modulate the activity of neuromediator receptors, including TRPV1, P2X3, and opioid receptors, which partially explains the sensory modulation, analgesic, and spasmolytic action. These mechanisms are also coupled with the regulation of calcium channels and ion gradients, affecting the tone of the smooth muscles of the gastrointestinal tract and the vascular bed.

References: https://doi.org/10.1016/j.fito...; https://pubchem.ncbi.nlm.nih.g...

Thus, the mechanism of action of Euphorbia fischeriana is based on a multiple effect on cellular enzymes, receptors, and signaling cascades, with the involvement of inflammatory, apoptotic, and antioxidant pathways. The participation of COX-2, iNOS, NF-κB, MAPK, caspases, TRPV1, and Nrf2 has been reliably confirmed.


Synergy — Euphorbia fischeriana

Experimental and pharmacological data confirm that Euphorbia fischeriana exhibits a synergistic interaction with various groups of natural and synthetic substances. The most pronounced potentiating synergy is with polyphenolic compounds (e.g., flavonoids), which is explained by additional activation of the Nrf2/ARE cascade and enhancement of the antioxidant response. The combination with compounds regulating the cyclooxygenase pathway (e.g., terpenes and glycosides) demonstrates an additive effect in suppressing prostaglandin synthesis, thereby enhancing the anti-inflammatory action.

References: https://www.sciencedirect.com/...; https://www.ncbi.nlm.nih.gov/p...

In vivo studies show that the combination of Euphorbia fischeriana with substances inhibiting the PI3K/Akt signaling pathway enhances the apoptotic effect and suppression of cell proliferation. This potentiating mechanism is realized through enhanced expression of caspases and suppression of Bcl-2, with simultaneous blockade of Akt phosphorylation. This type of synergy is characteristic of combinations with ligand-containing or alkaloid extracts.

References: https://pubs.rsc.org/en/conten...; https://www.tandfonline.com/do...

A functional complementation of the immunomodulatory action of Euphorbia fischeriana in combination with β-glucans and saponins has also been described, due to the activation of macrophages, increased production of interleukin-12, and stimulation of the differentiation of type 1 T-helpers. Such an action leads to systemic activation of the innate immune response.

References: https://www.sciencedirect.com/...; https://www.ncbi.nlm.nih.gov/p...

Thus, Euphorbia fischeriana exhibits a high potential for synergy with other plant components due to the modulation of common biochemical and signaling pathways, primarily inflammatory, apoptotic, and immune. The combination with other substances allows enhancing the effects at the systemic and cellular levels.


Geography of Use and Traditional Medicine — Euphorbia fischeriana

Euphorbia fischeriana is traditionally used in the folk medicine of China, Mongolia, Korea, and the eastern regions of Russia, primarily in the Far East, Primorye, and the Amur region. In Chinese traditional medicine, the plant is known under the name "Langdu" (狼毒) and is included in pharmacopoeial collections as a remedy with pronounced cleansing, warming, and thinning properties. The first mentions of its use date back to the Tang dynasty period (7th–10th centuries), where it figured in treatises as a component of cleansing preparations. In the territory of Korea, the rhizome of the plant was used in the form of decoction and powder, predominantly for external and internal cleansing, including with elements of ritual ablution.

In the folk medicine of the Buryats, Evenks, and Daurs, the plant was used in the form of decoctions and burnt powder applied to the skin or inhaled as smoke. The scope of application covered both bodily practices and ritual actions aimed at "removing evil from the body" and restoring vital force. Among the Tungus-Manchurian tribes, practices of smoking the dried rhizome of Euphorbia fischeriana during trance ceremonies have been recorded. It was believed that the bitter taste and irritating aroma of the plant contribute to the "purification of the spirit" and "expulsion of disease," and the milky sap was used externally in rites of expelling ailment.

In Tibetan medicine, the plant is mentioned as "me-tshe" and is used predominantly in cleansing formulations to balance the initial constitutions (in particular, the imbalance of wind and phlegm). Here it was prepared as part of complex phyto-preparations and was also used in the form of oil infusions used for rubbings.

In the folk practices of the Amur region, as well as in the Old Believer communities of Siberia, Euphorbia fischeriana was collected on certain days of the lunar cycle, considering it a "plant of power." The roots were dried, kept in sacred places of the home, and added to fumigations during epidemics. There were beliefs that the spurge root, placed at the head of the bed or in the hut, "wards off diseases and evil spirits." Some ethnographic sources indicate the use of the plant as an amulet or protective agent for domestic animals.

Specifications
Product type Powder, Extract
Weight 100 g
Made by Asiabiopharm Co Ltd
Country of origin Thailand
Reviews